Stock Price
54.71
Daily Change
-1.44 -2.56%
Monthly
20.56%
Yearly
-58.27%
Q3 Forecast
54.42

Novo Nordisk reported DKK118.72B in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
ANI Pharmaceuticals USD 621.56M 1.26M Jun/2025
Aurora Cannabis CAD 101.63M 648K Jun/2025
Bausch Health Companies USD 21.74B 228M Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Canopy Growth CAD 327.8M 161.87M Jun/2025
Corcept Therapeutics USD 6.6M 6.6M Jun/2025
Drreddys Laboratories INR 48.64B 2.44B Jun/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Merck USD 34.84B 2.27B Mar/2025
Novartis USD 31.27B 12M Mar/2025
Novo Nordisk 118.72B 61.75B Mar/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Pacira USD 580.49M 2.88M Jun/2025
Perrigo USD 3.65B 24.4M Jun/2025
Prestige Brands USD 1.04B 27.25M Jun/2025
Sanofi 22.28B 1.24B Jun/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
Zoetis USD 6.79B 214M Jun/2025